About this Event
The mRNA-based COVID-19 vaccines made history as the first RNA-based vaccines to be FDA approved for use in humans. Now, University of Rochester Medical Center (URMC) researchers and clinicians are studying how COVID-19 affects different populations, such as individuals with intellectual and developmental disabilities or those who are pregnant, and how we can apply mRNA technology to treat other illnesses. During this session, you will hear the latest on mRNA flu and pediatric vaccine trials, how vaccines are preventing serious breakthrough cases, and future vaccine boosters. Panelists will also take live questions from the audience.
Experience Rochester is a series of events created to bring the very best of Rochester directly to you. This special series exemplifies the University of Rochester’s commitment to lifelong learning. Although currently being launched through online events, this is a permanent program that will be devoted to featuring topics and speakers unique to the University. Expand your knowledge and fulfill your intellectual curiosity through Experience Rochester.
A link and information on how to join the lecture will be included in your registration confirmation email
0 people are interested in this event